10 results

• Risks with Niaspan or Trilipix Together With Statins Outweigh Benefits: FDA

  April 26, 2016

  Martha Garcia

  The FDA has removed indications that Niaspan and Trilipix should be used with statin cholesterol drugs and has also withdrawn approval for the marketing and sale of Advicor and Simcor due to stroke and muscle risks.

• Study Identifies Potential Risk of Cataracts with Lipitor, Zocor, Other Statins

  September 20, 2013

  Irvin Jackson

  Popular cholesterol drugs such as Lipitor and Crestor may increase the risk of developing cataracts, according to a new study.

• Statin Cholesterol Drug Prescriptions Often Unnecessary: Study

  March 14, 2013

  Irvin Jackson

  Doctors frequently prescribe cholesterol-fighting drugs that may carry a risk of significant side effects, even though there is limited evidence...

• Statin Diabetes Risk Does Not Outweigh Benefits: Study

  August 13, 2012

  Martha Garcia

  Researchers indicate that despite an increased risk of acquiring type 2 diabetes from statin medications, such as Crestor and Lipitor,...

• Statins Side Effects Can Cause Diabetes, Memory Loss, FDA Warns

  February 29, 2012

  Staff Writers

  Federal health regulators are warning that cholesterol lowering drugs like Lipitor, Crestor and Zocor could increase the risk of diabetes,...

• Recall of Zocor 80mg Dose Should Have Been Issued: Consumer Group

  June 10, 2011

  Staff Writers

  The FDA did not go far enough in restricting the use of high doses of the cholesterol drug Zocor, and...

• Zocor Muscle Injury Risk Leads to FDA Warning Over High Dose Simvastatin

  June 9, 2011

  Staff Writers

  Federal drug safety reviewers are calling for limits use of the highest dose of the cholesterol drug simvastatin, which is...

• Rhabdomyolysis Lawsuit

  June 1, 2011

  AboutLawsuits

  A number of different prescription medications have been linked to an increased risk of the serious and potentially fatal muscle...

• Zocor Rhabdomyolysis Muscle Injury Warning Issued by FDA

  March 22, 2010

  Staff Writers

  High doses of the cholesterol-fighting drug Zocor can increase the risk of rhabdomyolysis, a serious and potentially fatal muscle disease,...

• Rhabdomyolysis Warning Issued by FDA

  August 11, 2008

  AboutLawsuits

  The FDA issued an alert on Friday to remind doctors and the public about the risk of rhabdomyolysis, a rare...